NEW ACTIVE PHARMACEUTICAL INGREDIENTS FUNDAMENTALS EXPLAINED

“The present circumstance has uncovered some structural weaknesses during the EU’s medicines supply chain and also a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She suggested that supply chain concerns be resolved in an EU pharmaceutical strategy expected to be releas